Odoxil 250 DT Tablet contains Cefadroxil 250 mg, a first-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and some gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and pharyngitis caused by susceptible organisms. Cefadroxil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible form, allowing for ease of administration, particularly in pediatric and geriatric patients who may have difficulty swallowing conventional tablets. Odoxil 250 DT is absorbed well orally, achieving therapeutic plasma concentrations that facilitate effective bacterial eradication. It is generally well tolerated, with adverse effects being infrequent and mild, including gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Hypersensitivity reactions may occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be adjusted based on the severity of infection, renal function, and patient age. It is essential to complete the full prescribed course to prevent the development of resistance. Odoxil 250 DT should be used under medical supervision to ensure appropriate use and monitoring.